Diabetic foot osteomyelitis: Bone markers and treatment outcomes

Diabetes Research and Clinical Practice

Volumn 97, Issue 3, 2012, Pages 411-417

  Nyazee, Humaa A ^a   Finney, Kristina M ^a   Sarikonda, Molly ^a   Towler, Dwight A ^a   Johnson, Jeffrey E ^a   Babcock, Hilary M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone markers; Diabetic foot ulcers; Osteomyelitis; Treatment outcomes

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL TELOPEPTIDE; BIOLOGICAL MARKER;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETIC FOOT; DIABETIC PATIENT; FEMALE; FOLLOW UP; FOOT AMPUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOMYELITIS; PROTEIN BLOOD LEVEL; SAMPLE SIZE; TREATMENT OUTCOME;

ADULT; ALGORITHMS; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE AND BONES; CASE-CONTROL STUDIES; COHORT STUDIES; COLLAGEN TYPE I; DIABETIC FOOT; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOMYELITIS; PEPTIDES; PROGNOSIS; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84866564833     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.04.002     Document Type: Article

References (25)

1. Lipsky B.A. Osteomyelitis of the foot in diabetic patients. Clin Infect Dis 1997, 25:1318-1326.
2. Lipsky B.A., Peters E.J.G., Senneville E., Berendt A.R., Embil J.M., Lavery L.A., et al. Expert opinion on the management of infections in the diabetic foot. Diabetes Metab Res Rev 2012, 28(Suppl. 1):163-178.
3. Peters E.J.G., Lipsky B.A., Berendt A.R., Embil J.M., Lavery L.A., Senneville E., et al. A systematic review of the effectiveness of interventions in the management of infection in the diabetic foot. Diabetes Metab Res Rev 2012, 28(Suppl. 1):142-162.
4. US Department of Health and Human Services, Healthy People 2020. Healthy People 2020 summary of objectives. Retrieved from 2010 [accessed 10.02.11]. http://www.healthypeople.gov/.
5. Mader J.T., Shirtliff M.E., Bergquist S.C., Calhoun J. Antimicrobial treatment of chronic osteomyelitis. Clin Orthop Relat Res 1999, 4:7-65.
6. Warnke P.H., Springer I.N., Russo P.A., Wiltfang J., Essig H., Kosmahl M., et al. Innate immunity in human bone. Bone 2006, 38:400-408.
7. Marriott I., Gray D.L., Rati D.M., Fowler V.G., Stryjewski M.E., Levin L.S., et al. Osteoblasts produce monocyte chemoattractant protein-1 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissue. Bone 2005, 37:504-512.
8. Fink E., Cormier C., Steinmetz P., Kindermans C., Le Bouc Y., Souberbielle J.C. Differences in the capacity of several biochemical bone markers to assess high bone turnover in early menopause and response to alendronate therapy. Osteoporos Int 2000, 11:295-303.
9. Nakai T., Kanbara N. Serum crosslinked N-terminal telopeptide of type 1 collagen for evaluation of bone loss in hemodialysis patients using dual-energy X-ray absorptiometry. Dial Transplant 2007, 1-3.
10. Scariano J.K., Garry P.J., Montoya G.D., Duran-Valdez E., Baumgartner R.N. Diagnostic efficacy of serum cross-linked N-telopeptide (NTx) and aminoterminal procollagen extension propeptide (PINP) measurements for identifying elderly women with decreased bone mineral density. Scand J Clin Lab Invest 2002, 62:237-243.
11. Pennisi P., Signorelli S.S., Riccobene S., Celotta G., Di Pino L., La Malfa T., et al. Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporos Int 2004, 15:389-395.
12. Kemink S.A., Hermus A.R., Swinkels L.M., Lutterman J.A., Smals A.G. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology. J Endocrinol Invest 2000, 23:295-303.
13. Hannon R.A., Eastell R. Bone markers and current laboratory assays. Cancer Treat Rev 2006, 32(Suppl. 1):7-14.
14. Kelman A., Lui L., Yao W., Krumme A., Nevitt M., Lane N.E. Association of higher levels of serum cartilage oligomeric matrix protein and N-telopeptide crosslinks with the development of radiographic hip osteoarthritis in elderly women. Arthritis Rheum 2006, 54:236-243.
15. Clemens J.D., Herrick M.V., Singer F.R., Eyre D.R. Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption. Clin Chem 1997, 43:2058-2063.
16. Lipton A., Cook R., Saad F., Major P., Garnero P., Terpos E., et al. Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid. Cancer 2008, 113:193-201.
17. Ross P.D., Kress B.C., Parson R.E., Wasnich R.D., Armour K.A., Mizrahi I.A. Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study. Osteoporos Int 2000, 11:76-82.
18. Philipov J.P., Pascalev M.D., Aminkov B.Y., Grosev C.D. Changes in serum carboxyterminal telopeptide of type I collagen in an experimental model of canine osteomyelitis. Calcif Tissue Int 1995, 57:152-154.
19. Southwood L.L., Frisbie D.D., Kawcak C.E., McIlwraith C.W. Evaluation of serum biochemical markers of bone metabolism for early diagnosis of nonunion and infected nonunion fractures in rabbits. Am J Vet Res 2003, 64:727-735.
20. Springer I.N., Wiltfang J., Dunsche A., Lier G.C., Bartsch M., Warnke P.H., et al. A new method of monitoring osteomyelitis. Int J Oral Maxillofac Surg 2007, 36:527-532.
21. Senneville E., Melliez H., Beltrand E., Legout L., Valette M., Cazaubiel M., et al. Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures. Clin Infect Dis 2006, 42:57-62.
22. Kayal R.A., Tsatsas D., Bauer M.A., Allen B., Al-Sebaei M.O., Kakar S., et al. Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity. J Bone Miner Res 2007, 22:560-568.
23. Christenson R.H. Biochemical markers of bone metabolism: an overview. Clin Biochem 1997, 30:573-593.
24. Takahashi N., Toshihisa K., Hiroshi O., Ishiguro N. Correlation between parathyroid hormone, bone alkaline phosphatase and N-telopeptide of type 1 collagen in diabetic and non-diabetic haemodialysis patients. Nephrology 2007, 12:539-545.
25. Brown J.E., Chow E. Bone biomarkers in research and clinical practice. Bone metastases: a translational and clinical approach (Cancer metastasis - biology and treatment) 2009, 93-116. Springer, Netherlands. 1st ed. D. Kardamakis, V. Vassiliou, E. Chow (Eds.).